(Q40065389)

English

TLR4/MD-2 monoclonal antibody therapy affords protection in experimental models of septic shock

scientific article published on November 2007

Statements

TLR4/MD-2 monoclonal antibody therapy affords protection in experimental models of septic shock (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit